Tatva Chintan Pharma Chem Balance Sheet Health
Financial Health criteria checks 6/6
Tatva Chintan Pharma Chem has a total shareholder equity of ₹7.4B and total debt of ₹142.7M, which brings its debt-to-equity ratio to 1.9%. Its total assets and total liabilities are ₹8.2B and ₹816.4M respectively. Tatva Chintan Pharma Chem's EBIT is ₹501.0M making its interest coverage ratio 7.7. It has cash and short-term investments of ₹483.4M.
Key information
1.9%
Debt to equity ratio
₹142.71m
Debt
| Interest coverage ratio | 7.7x |
| Cash | ₹483.43m |
| Equity | ₹7.37b |
| Total liabilities | ₹816.36m |
| Total assets | ₹8.19b |
Recent financial health updates
No updates
Recent updates
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion
Apr 04
These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts
Jan 26Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year
May 10Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next
Jul 28Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely
Jun 17Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings
May 03Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?
Dec 06Financial Position Analysis
Short Term Liabilities: TATVA's short term assets (₹3.0B) exceed its short term liabilities (₹796.6M).
Long Term Liabilities: TATVA's short term assets (₹3.0B) exceed its long term liabilities (₹19.7M).
Debt to Equity History and Analysis
Debt Level: TATVA has more cash than its total debt.
Reducing Debt: TATVA's debt to equity ratio has reduced from 96.8% to 1.9% over the past 5 years.
Debt Coverage: TATVA's debt is well covered by operating cash flow (687%).
Interest Coverage: TATVA's interest payments on its debt are well covered by EBIT (7.7x coverage).